BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 12221096)

  • 1. XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC.
    Arthur WT; Ellerbroek SM; Der CJ; Burridge K; Wennerberg K
    J Biol Chem; 2002 Nov; 277(45):42964-72. PubMed ID: 12221096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Divergence of Rho residue 43 impacts GEF activity.
    Sloan CM; Quinn CV; Peters JP; Farley J; Goetzinger C; Wernli M; DeMali KA; Ellerbroek SM
    Small GTPases; 2012; 3(1):15-22. PubMed ID: 22673745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the Rho-specific guanine nucleotide-exchange factor Xpln.
    Murayama K; Kato-Murayama M; Akasaka R; Terada T; Yokoyama S; Shirouzu M
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Dec; 68(Pt 12):1455-9. PubMed ID: 23192023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel strategy for specifically down-regulating individual Rho GTPase activity in tumor cells.
    Wang L; Yang L; Luo Y; Zheng Y
    J Biol Chem; 2003 Nov; 278(45):44617-25. PubMed ID: 12939257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SmgGDS is a guanine nucleotide exchange factor that specifically activates RhoA and RhoC.
    Hamel B; Monaghan-Benson E; Rojas RJ; Temple BR; Marston DJ; Burridge K; Sondek J
    J Biol Chem; 2011 Apr; 286(14):12141-8. PubMed ID: 21242305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights into specificity, activity, and regulatory elements of the regulator of G-protein signaling (RGS)-containing Rho-specific guanine nucleotide exchange factors (GEFs) p115, PDZ-RhoGEF (PRG), and leukemia-associated RhoGEF (LARG).
    Jaiswal M; Gremer L; Dvorsky R; Haeusler LC; Cirstea IC; Uhlenbrock K; Ahmadian MR
    J Biol Chem; 2011 May; 286(20):18202-12. PubMed ID: 21454492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG.
    Zalcman G; Closson V; Camonis J; Honoré N; Rousseau-Merck MF; Tavitian A; Olofsson B
    J Biol Chem; 1996 Nov; 271(48):30366-74. PubMed ID: 8939998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Leukaemia Associated Rho GEF (LARG/ARHGEF12).
    Ghanem NZ; Matter ML; Ramos JW
    Small GTPases; 2022 Jan; 13(1):196-204. PubMed ID: 34304710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho isoform-specific interaction with IQGAP1 promotes breast cancer cell proliferation and migration.
    Casteel DE; Turner S; Schwappacher R; Rangaswami H; Su-Yuo J; Zhuang S; Boss GR; Pilz RB
    J Biol Chem; 2012 Nov; 287(45):38367-78. PubMed ID: 22992742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling.
    Kubo T; Yamashita T; Yamaguchi A; Sumimoto H; Hosokawa K; Tohyama M
    J Neurosci; 2002 Oct; 22(19):8504-13. PubMed ID: 12351724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain.
    Soh UJ; Low BC
    J Cell Sci; 2008 May; 121(Pt 10):1739-49. PubMed ID: 18445682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoA-GDP regulates RhoB protein stability. Potential involvement of RhoGDIalpha.
    Ho TT; Merajver SD; Lapière CM; Nusgens BV; Deroanne CF
    J Biol Chem; 2008 Aug; 283(31):21588-98. PubMed ID: 18524772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural determinants of RhoA binding and nucleotide exchange in leukemia-associated Rho guanine-nucleotide exchange factor.
    Kristelly R; Gao G; Tesmer JJ
    J Biol Chem; 2004 Nov; 279(45):47352-62. PubMed ID: 15331592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse macrophages completely lacking Rho subfamily GTPases (RhoA, RhoB, and RhoC) have severe lamellipodial retraction defects, but robust chemotactic navigation and altered motility.
    Königs V; Jennings R; Vogl T; Horsthemke M; Bachg AC; Xu Y; Grobe K; Brakebusch C; Schwab A; Bähler M; Knaus UG; Hanley PJ
    J Biol Chem; 2014 Oct; 289(44):30772-30784. PubMed ID: 25213860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.
    Wheeler AP; Ridley AJ
    Exp Cell Res; 2004 Nov; 301(1):43-9. PubMed ID: 15501444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of p190RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules.
    van Horck FP; Ahmadian MR; Haeusler LC; Moolenaar WH; Kranenburg O
    J Biol Chem; 2001 Feb; 276(7):4948-56. PubMed ID: 11058585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activation.
    Chinestra P; Olichon A; Medale-Giamarchi C; Lajoie-Mazenc I; Gence R; Inard C; Ligat L; Faye JC; Favre G
    PLoS One; 2014; 9(11):e111034. PubMed ID: 25365345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases.
    Ren Y; Li R; Zheng Y; Busch H
    J Biol Chem; 1998 Dec; 273(52):34954-60. PubMed ID: 9857026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vav2 is an activator of Cdc42, Rac1, and RhoA.
    Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
    J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the selective activation of Rho GTPases by Dbl exchange factors.
    Snyder JT; Worthylake DK; Rossman KL; Betts L; Pruitt WM; Siderovski DP; Der CJ; Sondek J
    Nat Struct Biol; 2002 Jun; 9(6):468-75. PubMed ID: 12006984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.